Rodent models of tumours of the central nervous system

被引:1
|
作者
Brandner, Sebastian [1 ,2 ]
机构
[1] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, Queen Sq,Queen Sq House, London WC1N 3BG, England
[2] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, NHS Fdn Trust, Div Neuropathol, Queen Sq House,Queen Sq, London WC1N 3BG, England
关键词
brain tumour; Cre-lox system; CRISPR Cas9 system; genetically modified mouse model; glioblastoma; medulloblastoma; SITE-SPECIFIC RECOMBINATION; NEURAL STEM-CELLS; PRIMITIVE NEUROECTODERMAL TUMORS; MUTAGENESIS IDENTIFIES GENES; CHOROID-PLEXUS TUMORS; PEDIATRIC HIGH-GRADE; HUMAN-BRAIN-TUMORS; LARGE-T-ANTIGEN; SONIC HEDGEHOG; GROWTH-FACTOR;
D O I
10.1002/1878-0261.13729
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Modelling of human diseases is an essential component of biomedical research, to understand their pathogenesis and ultimately, develop therapeutic approaches. Here, we will describe models of tumours of the central nervous system, with focus on intrinsic CNS tumours. Model systems for brain tumours were established as early as the 1920s, using chemical carcinogenesis, and a systematic analysis of different carcinogens, with a more refined histological analysis followed in the 1950s and 1960s. Alternative approaches at the time used retroviral carcinogenesis, allowing a more topical, organ-centred delivery. Most of the neoplasms arising from this approach were high-grade gliomas. Whilst these experimental approaches did not directly demonstrate a cell of origin, the localisation and growth pattern of the tumours already pointed to an origin in the neurogenic zones of the brain. In the 1980s, expression of oncogenes in transgenic models allowed a more targeted approach by expressing the transgene under tissue-specific promoters, whilst the constitutive inactivation of tumour suppressor genes ('knock out')-often resulted in embryonic lethality. This limitation was elegantly solved by engineering the Cre-lox system, allowing for a promoter-specific, and often also time-controlled gene inactivation. More recently, the use of the CRISPR Cas9 technology has significantly increased experimental flexibility of gene expression or gene inactivation and thus added increased value of rodent models for the study of pathogenesis and establishing preclinical models. We describe the evolution of experimental systems, illustrated here in a timeline to show changing popularity over time. Starting with chemical and viral carcinogenesis, systems then developed into increasingly sophisticated genetically modified animal models. The literature cited in this article corresponds to the arrows in this illustration and the schematics illustrate the mechanism of action described in this article. image
引用
收藏
页码:2842 / 2870
页数:29
相关论文
共 50 条
  • [21] Corticosteroids in the management of central nervous system tumours
    Glaser, AW
    Buxton, N
    Walker, D
    ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (01) : 76 - 78
  • [22] Chemotherapy of central nervous system tumours in infants
    Kellie, SJ
    CHILDS NERVOUS SYSTEM, 1999, 15 (10) : 592 - 612
  • [23] PHOSPHOLIPIDS AND GLYCOLIPIDS OF TUMOURS IN CENTRAL NERVOUS SYSTEM
    LOU, HOC
    CLAUSEN, J
    BIERRING, F
    JOURNAL OF NEUROCHEMISTRY, 1965, 12 (07) : 619 - +
  • [24] Developments in the Management of Central Nervous System Tumours
    Burnet, N. G.
    CLINICAL ONCOLOGY, 2014, 26 (07) : 361 - 363
  • [25] FAMILIAL OCCURRENCE OF TUMOURS OF CENTRAL NERVOUS SYSTEM
    BROMOWIC.J
    KINDERMA.B
    ACTA NEUROLOGICA SCANDINAVICA, 1967, 43 (02): : 252 - &
  • [26] Neuronal expression of muskelin in the rodent central nervous system
    Nadia Tagnaouti
    Sven Loebrich
    Frank Heisler
    Yvonne Pechmann
    Susanne Fehr
    Adèle De Arcangelis
    Elisabeth Georges-Labouesse
    Josephine C Adams
    Matthias Kneussel
    BMC Neuroscience, 8
  • [27] In vivo Optogenetic Stimulation of the Rodent Central Nervous System
    Sidor, Michelle M.
    Davidson, Thomas J.
    Tye, Kay M.
    Warden, Melissa R.
    Diesseroth, Karl
    McClung, Colleen A.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (95):
  • [28] Neuronal expression of muskelin in the rodent central nervous system
    Tagnaouti, Nadia
    Loebrich, Sven
    Heisler, Frank
    Pechmann, Yvonne
    Fehr, Susanne
    De Arcangelis, Adele
    Georges-Labouesse, Elisabeth
    Adams, Josephine C.
    Kneussel, Matthias
    BMC NEUROSCIENCE, 2007, 8 (1)
  • [29] Ionizing radiation-induced risks to the central nervous system and countermeasures in cellular and rodent models
    Pariset, Eloise
    Malkani, Sherina
    Cekanaviciute, Egle
    Costes, Sylvain, V
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2021, 97 : S132 - S150
  • [30] The 2007 WHO classification of tumours of the central nervous system
    Louis, David N.
    Ohgaki, Hiroko
    Wiestler, Otmar D.
    Cavenee, Webster K.
    Burger, Peter C.
    Jouvet, Anne
    Scheithauer, Bernd W.
    Kleihues, Paul
    ACTA NEUROPATHOLOGICA, 2007, 114 (02) : 97 - 109